DECODING THE SANOFI PASTEUR DENGUE VACCINE INFECTIVITY AND IMMUNOGENICITY USING THE HUMAN IN VITRO MIMIC® SYSTEM

被引：0
|
作者：
Luna, Ernesto [1 ]
Chehtane, Mounir [1 ]
Agrawal, Pankaj [1 ]
Mehta, Riyaz [1 ]
Byers, Anthony [1 ]
Schanen, Brian [1 ]
Guy, Bruno [2 ]
Jackson, Nicholas [2 ]
Warren, William [1 ]
Moser, Janice M. [1 ]
机构：
[1] Sanofi Pasteur, Orlando, FL USA
[2] Sanofi Pasteur, Lyon, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1362
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [21] From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
    Guy, Bruno
    Barrere, Beatrice
    Malinowski, Claire
    Saville, Melanie
    Teyssou, Remy
    Lang, Jean
    VACCINE, 2011, 29 (42) : 7229 - 7241
  • [22] Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
    Qiao, Ming
    Shaw, David
    Forrat, Remi
    Wartel-Tram, Anh
    Lang, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (04): : 724 - 731
  • [23] Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
    Kanesa-thasan, N
    Sun, W
    Kim-Ahn, G
    Van Albert, S
    Putnak, JR
    King, A
    Raengsakulsrach, B
    Christ-Schmidt, H
    Gilson, K
    Zahradnik, JM
    Vaughn, DW
    Innis, BL
    Saluzzo, JF
    Hoke, CH
    VACCINE, 2001, 19 (23-24) : 3179 - 3188
  • [24] COMPLEMENTARY USE OF CRYO-ELECTRON MICROSCOPY AND MASS SPECTROMETRY TO ASSESS THE MATURITY OF SANOFI PASTEUR DENGUE VACCINE VIRUSES
    Trauchessec, Mathieu
    Bonnafous, Pierre
    Lambert, Olivier
    Berard, Yves
    Barriere, Fabienne
    Huillet, Celine
    Sirohi, Devika
    Kuhn, Richard
    Guy, Bruno
    Ronzon, Frederic
    Manin, Catherine
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 36 - 36
  • [25] SEROTYPE-SPECIFIC CHARACTERISTICS OF THE NEUTRALIZING ANTIBODY RESPONSE TO THE SANOFI PASTEUR DENGUE VACCINE IN PHASE III EFFICACY TRIALS
    Byers, Anthony M.
    Ross, Shanti
    Shaik, S. Farzana
    Peredelchuk, Michael
    Vernhes, Charlotte
    de Montfort, Aymeric
    Small, Robert
    Bonaparte, Matthew
    de Silva, Aravinda
    Moser, Janice M.
    Guy, Bruno
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 426 - 426
  • [26] Site-specific characterization of envelope protein N-glycosylation on Sanofi Pasteur's tetravalent CYD dengue vaccine
    Dubayle, Jean
    Vialle, Sandrine
    Schneider, Diane
    Pontvianne, Jeremy
    Mantel, Nathalie
    Adam, Olivier
    Guy, Bruno
    Talaga, Philippe
    VACCINE, 2015, 33 (11) : 1360 - 1368
  • [27] Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? Questions Raised by the Development and Implementation of Dengue Vaccines: Example of the Sanofi Pasteur Tetravalent Dengue Vaccine
    Guy, Bruno
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (06):
  • [28] Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
    Whitehead, Stephen S.
    EXPERT REVIEW OF VACCINES, 2016, 15 (04) : 509 - 517
  • [29] Insulin and free insulin measurements using the Sanofi Diagnostics Pasteur Inc ACCESS(R) System.
    Russell, A
    Johnson, G
    CLINICAL CHEMISTRY, 1996, 42 (06) : 149 - 149
  • [30] USE OF A BIOLAYER INTERFEROMETRY-BASED ASSAY TO DETERMINE ANTIBODY AFFINITY TO DENV FOLLOWING IMMUNIZATION WITH THE SANOFI PASTEUR DENGUE VACCINE IN PHASE II AND PHASE III CLINICAL TRIALS
    Munteanu, Alina
    Karol, Alexander
    de Montfort, Aymeric
    Bonaparte, Matthew
    Guy, Bruno
    Moser, Janice
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 426 - 426
12345